These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1039 related items for PubMed ID: 27038847

  • 21. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT, Chang KC, Li CY, Wu JS.
    Cardiovasc Diabetol; 2016 Mar 01; 15():41. PubMed ID: 26932742
    [Abstract] [Full Text] [Related]

  • 22. Cost-Effectiveness of Dipeptidylpeptidase-4 Inhibitors Added to Metformin in Patients With Type 2 Diabetes in China.
    Lin WQ, Cai ZJ, Chen T, Liu MB, Li N, Zheng B.
    Front Endocrinol (Lausanne); 2021 Mar 01; 12():684960. PubMed ID: 34484112
    [Abstract] [Full Text] [Related]

  • 23. Demographic and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Study of UK General Practice.
    Tebboth A, Lee S, Scowcroft A, Bingham-Gardiner P, Spencer W, Bolodeoku J, Hassan SW.
    Clin Ther; 2016 Aug 01; 38(8):1825-1832.e15. PubMed ID: 27491279
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.
    Scheen AJ.
    Diabetes Obes Metab; 2010 Aug 01; 12(8):648-58. PubMed ID: 20590741
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and Cardiovascular Safety of DPP-4 Inhibitors.
    Subrahmanyan NA, Koshy RM, Jacob K, Pappachan JM.
    Curr Drug Saf; 2021 Aug 01; 16(2):154-164. PubMed ID: 32819262
    [Abstract] [Full Text] [Related]

  • 26. Tolerability of dipeptidyl peptidase-4 inhibitors: a review.
    Richard KR, Shelburne JS, Kirk JK.
    Clin Ther; 2011 Nov 01; 33(11):1609-29. PubMed ID: 22071236
    [Abstract] [Full Text] [Related]

  • 27. Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure: A Network Meta-Analysis.
    Guo WQ, Li L, Su Q, Dai WR, Ye ZL.
    Value Health; 2017 Dec 01; 20(10):1427-1430. PubMed ID: 29241903
    [Abstract] [Full Text] [Related]

  • 28. Alogliptin; a review of a new dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes mellitus.
    Said S, Nwosu AC, Mukherjee D, Hernandez GT.
    Cardiovasc Hematol Disord Drug Targets; 2014 Dec 01; 14(1):64-70. PubMed ID: 24993124
    [Abstract] [Full Text] [Related]

  • 29. A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes.
    Gallwitz B.
    Expert Opin Drug Saf; 2017 Dec 01; 16(12):1399-1405. PubMed ID: 28934557
    [Abstract] [Full Text] [Related]

  • 30. An update on the 'gliptins'.
    Drug Ther Bull; 2016 Dec 01; 54(12):138-141. PubMed ID: 27979881
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular Effects of Incretin-Based Therapies.
    White WB, Baker WL.
    Annu Rev Med; 2016 Dec 01; 67():245-60. PubMed ID: 26768240
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial.
    Santamarina M, Carlson CJ.
    BMC Cardiovasc Disord; 2019 Mar 15; 19(1):60. PubMed ID: 30876392
    [Abstract] [Full Text] [Related]

  • 39. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.
    Li L, Li S, Deng K, Liu J, Vandvik PO, Zhao P, Zhang L, Shen J, Bala MM, Sohani ZN, Wong E, Busse JW, Ebrahim S, Malaga G, Rios LP, Wang Y, Chen Q, Guyatt GH, Sun X.
    BMJ; 2016 Feb 17; 352():i610. PubMed ID: 26888822
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.